Fabio
3.6 KiB
3.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Establishes an affirmative defense for damages for any claim relating to genetically engineered organisms | Establishes an affirmative defense for causes of actions related to damages for any claim on grounds that a party possessed or used seeds or plants that contained genetically engineered or genetically modified organisms without entering into an agreement or paying fees to the manufacturer or licensed distributor of such products. | us/states/ny | New York Legislature | 2019-2020 | A 1104 | New York A 1104 (2019-2020) |
|
enacted |
|
2 | 20 | 4 | 2019-01-14 | 2019-12-06 | openstates | ocd-bill/069538c6-fb84-474f-89de-71ad5d68a268 | http://www.nysenate.gov/legislation/bills/2019/A1104 | e14ff1f20dcd917e134c25b2fc2b4a87d62a453676e0c909de09259452732a7d | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York A 1104 (2019-2020) — Establishes an affirmative defense for damages for any claim relating to genetically engineered organisms
Establishes an affirmative defense for causes of actions related to damages for any claim on grounds that a party possessed or used seeds or plants that contained genetically engineered or genetically modified organisms without entering into an agreement or paying fees to the manufacturer or licensed distributor of such products.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Floor Vote - Version: A — 58–0 (pass) · upper
- Assembly Vote — 145–0 (pass) · lower
- Assembly Vote - Vote 2 — 133–0 (pass) · lower
- MOTION:ABINANTI; To reconsider — 144–0 (pass) · lower
Sponsors
- ABINANTI — primary (person)
- WEPRIN — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2019-01-14 REFERRED TO JUDICIARY
referral-committee - 2019-01-28 REPORTED
- 2019-01-31 ADVANCED TO THIRD READING CAL.22
- 2019-02-05 PASSED ASSEMBLY
passage - 2019-02-05 DELIVERED TO SENATE
- 2019-02-05 REFERRED TO JUDICIARY
referral-committee - 2019-04-29 RECALLED FROM SENATE
- 2019-04-29 RETURNED TO ASSEMBLY
- 2019-04-29 VOTE RECONSIDERED - RESTORED TO THIRD READING
- 2019-04-29 AMENDED ON THIRD READING 1104A
amendment-passage - 2019-05-07 REPASSED ASSEMBLY
passage - 2019-05-07 RETURNED TO SENATE
- 2019-05-07 RECOMMITTED TO JUDICIARY
referral-committee - 2019-05-15 SUBSTITUTED FOR S4206A
- 2019-05-15 3RD READING CAL.433
- 2019-05-15 PASSED SENATE
passage - 2019-05-15 RETURNED TO ASSEMBLY
- 2019-11-26 DELIVERED TO GOVERNOR
executive-receipt - 2019-12-06 SIGNED CHAP.612
executive-signature - 2019-12-06 APPROVAL MEMO.32
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/069538c6-fb84-474f-89de-71ad5d68a268. Confidence: reported (aggregated from official New York legislature records).